The rising prevalence in GLP-1 agonists for diabetes has led to a question about delivery routes : skin-applied devices versus tablets . Traditionally , GLP-1 treatments were solely available in pill form, https://nannietpaz955611.blazingblog.com/40985935/glp-1-transdermal-delivery-systems-vs-oral-medications-what-right-for-the-patient